NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 7 நாட்களுக்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Blue Star Q2 FY27 Earnings Call: 21% Revenue Growth, Aims for 6.5% Segment Margins
Blue Star released its Q2 & H1 FY27 earnings call transcript, highlighting consolidated revenue growth of ~21% and operating profit growth of ~10.5%. The carried forward order book stood at Rs 7,229 cr as of September 30, 2026, representing ~56% of TTM revenue (Rs 12,797 cr), alongside a shift to a net cash position of Rs 289 cr. Management noted room air conditioner primary sales grew 42% in Q2, while targeting a recovery in cooling product segment margins to 6.5%. The company recently implemented a 5% price hike from October 1 to counter an 18% cumulative raw material inflation.
உச்சம் நம்பிக்கை
என்ன மாறியதுBlue Star published the full transcript of its Q2 and H1 FY27 earnings conference call held on October 30, 2026.
ஏன் இது முக்கியம்Provides granular operational clarity on margin pressures, working capital improvements, project execution delays, and strategy around price hikes and outsourcing.
Q2 Consolidated Revenue Growth: around 21%Carried forward order book: Rs. 7,229 crOrder book vs TTM revenue: ~56.5%Net Cash Position: Rs. 289 crOctober Price Hike: 5%
📅 குறுகிய காலம்Focus shifts to festive season sales and channel absorption of the 5% price hike announced in October.
📈 நீண்ட காலம்Outsourcing share may rise from 15% to 30% for entry-level products to protect margins, while international heat pump expansion and data center cooling remain key growth vectors.
⚠ அபாய எச்சரிக்கைகள்
Inability to fully pass on 18% cumulative raw material cost inflation
Monsoon shortfalls impacting Tier 3/4/5 town demand and rising consumer finance interest rates
Billing delays in the Electromechanical Projects segment due to execution slowdowns
👀 கவனிக்க வேண்டியவை
Track whether channel partners absorb the 5% October price hike and monitor if Unitary Cooling segment EBIT margins recover toward the guided 6.5% level in H2 FY27.
Blue Star Q2FY27 Results: Revenue Up 21% to ₹2,930.95 Cr; Net Profit Rises 25.4% to ₹123.91 Cr
Blue Star reported a 21.0% YoY rise in consolidated revenue from operations to ₹2,930.95 cr for Q2FY27, up from ₹2,422.37 cr in Q2FY26. Net profit grew 25.4% YoY to ₹123.91 cr, aided by an exceptional gain of ₹23.02 cr from the sale of the MedTech business concluded on August 31, 2026. However, operating margins faced pressure from unabsorbed raw material escalations, with Unitary Products EBIT margin falling 390 bps to 2.3% and Electro-Mechanical Projects margin contracting 190 bps to 6.9%. Carried-forward order book stood marginally higher at ₹7,229.22 cr (+1.5% YoY).
உச்சம் நம்பிக்கை
என்ன மாறியதுBlue Star released its revised Q2FY27 investor presentation following a correction on page 9, reporting solid topline growth but margin compression.
ஏன் இது முக்கியம்Demonstrates robust demand across Room ACs and project solutions, but operating profitability was dampened by input cost inflation and delayed project execution.
Revenue from operations (Q2FY27): ₹2,930.95 கோடிNet Profit (Q2FY27): ₹123.91 கோடிExceptional Gain (MedTech sale): ₹23.02 கோடிCarried-forward order book: ₹7,229.22 கோடிOrder book vs TTM revenue: ~56.5%
📅 குறுகிய காலம்Margin compression in Unitary Products (EBIT at 2.3%) is likely to temper investor sentiment despite healthy revenue expansion.
📈 நீண்ட காலம்Turnaround to a net cash balance sheet (-₹289.43 cr) and sustained order book of ₹7,229 cr provide balance sheet strength for long-term HVAC expansion.
⚠ அபாய எச்சரிக்கைகள்
Margin contraction across major segments due to inability to fully pass through material cost inflation
Subdued execution in electro-mechanical project business
👀 கவனிக்க வேண்டியவை
Monitor how effectively the company passes on raw material cost escalations in upcoming quarters and track order inflow execution in the commercial projects division.
Blue Star Q2 FY27 Revenue Up 21% to ₹2,931 Cr; PAT Rises 25.4% to ₹123.9 Cr on MedTech Sale
Blue Star Limited reported a 21.0% YoY increase in consolidated revenue from operations to ₹2,930.95 crore for Q2 FY27, up from ₹2,422.37 crore in Q2 FY26. EBITDA grew 10.5% YoY to ₹202.58 crore, while Net Profit increased 25.4% YoY to ₹123.91 crore, aided by an exceptional gain of ₹23.02 crore from the sale of its MedTech business completed on August 31, 2026. Profit before tax before exceptional items saw a marginal decline of 1.6% to ₹134.28 crore as material cost escalations compressed operating margins across major segments. The carried-forward order book stood at ₹7,229.22 crore as of September 30, 2026, representing about 56.5% of TTM revenue.
உச்சம் நம்பிக்கை
என்ன மாறியதுBlue Star released its Q2 FY27 investor presentation detailing quarterly financial performance, segment EBIT pressures, and the completion of its MedTech business divestment on August 31, 2026.
ஏன் இது முக்கியம்While top-line growth remained robust at 21%, operating profitability faces headwinds as cost increases were not fully passed on, compressing Unitary Products EBIT margins to 2.3%.
Q2 FY27 Revenue from Operations: ₹2,930.95 கோடிQ2 FY27 Net Profit (with exceptional items): ₹123.91 கோடிMedTech Exceptional Gain: ₹23.02 கோடிOrder Book (as of 30 Sep 2026): ₹7,229.22 கோடிOrder Book vs TTM Revenue: ~56.5%
📅 குறுகிய காலம்Markets are likely to view the headline top-line expansion positively, but underlying margin compression in the cooling and project segments (pre-exceptional PBT down 1.6%) could keep stock performance muted.
📈 நீண்ட காலம்Divestment of the non-core MedTech business streamlines focus onto core HVAC&R and export opportunities (US heat pumps), while healthy order books support sustained commercial demand.
⚠ அபாய எச்சரிக்கைகள்
Inability to fully pass on raw material cost escalations, depressing segment margins
Execution delays reported in the electro-mechanical project business
👀 கவனிக்க வேண்டியவை
Track whether price hikes successfully offset raw material escalations in the Unitary Products and EMP segments in H2, and monitor order inflow execution given the ₹7,229.22 crore order book.
Q2FY27 Revenue up 21% to ₹2,930.95 Cr; EBITDA Margins Contract to 6.9%
Blue Star reported a 21.0% YoY increase in consolidated revenue from operations for Q2FY27, reaching ₹2,930.95 crore, driven by extended summer demand for Room ACs. Operating profit (EBITDA excluding other income) grew 10.5% YoY to ₹202.58 crore, with operating margin contracting by 70 bps to 6.9% due to rising input material costs. Consolidated net profit rose 25.4% YoY to ₹123.91 crore, aided by an exceptional gain of ₹23.02 crore from the divestment of its MedTech business. The carried forward order book stood at ₹7,229.22 crore, and the company turned net cash positive at ₹289.43 crore compared to net debt of ₹417.06 crore in Q2FY26.
உச்சம் நம்பிக்கை
என்ன மாறியதுBlue Star released its Q2FY27 earnings showing healthy top-line expansion offset by margin compression, alongside completing the sale of its MedTech unit.
ஏன் இது முக்கியம்Demonstrates sustained market demand for RACs and cooling products, but highlights ongoing input cost pressures that the company is currently unable to fully pass through to consumers.
Q2FY27 Revenue: Rs 2930.95 croresQ2FY27 Operating Profit: Rs 202.58 croresநிகர லாபம்: Rs 123.91 croresCarried Forward Order Book: Rs 7229.22 croresOrder Book vs TTM Revenue: ~56.5%Net Cash Position: Rs 289.43 crores
📅 குறுகிய காலம்Market sentiment may be balanced between strong top-line delivery and the noticeable margin contraction in the consumer-facing Unitary Products segment.
📈 நீண்ட காலம்Data center MEP project orders and commercial air conditioning demand offer medium-term visibility, while improving balance sheet strength supports ongoing channel and export investments.
⚠ அபாய எச்சரிக்கைகள்
Material cost escalation with limited ability to pass on price increases, depressing segment margins.
Subdued billing growth in MEP segment due to project execution delays.
👀 கவனிக்க வேண்டியவை
Track the pace of price hikes and product rationalization in H2FY27 to gauge if Unitary Products margins can recover towards historical levels.
Blue Star Q2 FY27 Financial Results Approved; Net Operating Cash Flow Jumps to ₹214.71 Cr
Blue Star Limited approved its un-audited standalone and consolidated financial results for Q2 and H1 FY27 (period ended September 30, 2026). For the half-year ended September 30, 2026, standalone net cash generated from operating activities improved significantly to ₹214.71 crore, compared to an outflow of ₹678.11 crore in the corresponding previous period. Standalone exceptional income of ₹9.17 crore was recognized from the sale of property during H1 FY27. Additionally, five overseas subsidiaries generated ₹329.92 crore in revenue and ₹23.96 crore in PAT during the second quarter.
உச்சம் நம்பிக்கை
என்ன மாறியதுBlue Star concluded its board meeting approving reviewed financial results for the quarter and half-year ended September 30, 2026.
ஏன் இது முக்கியம்Demonstrates healthy working capital management with a turnaround to positive operating cash flow (₹214.71 crore) during the first half.
H1 FY27 Standalone Net Operating Cash Flow: ₹214.71 கோடிExceptional Profit on Sale of Property (H1): ₹9.17 கோடி5 Subsidiaries Q2 Revenue: ₹329.92 கோடி5 Subsidiaries Q2 Net Profit After Tax: ₹23.96 கோடிH1 Standalone Capex (PPE & Intangibles): ₹121.88 கோடி
📅 குறுகிய காலம்Market focus will center on consolidated profitability, segment revenue growth, and upcoming festive season/pre-BEE change inventory management.
📈 நீண்ட காலம்Solid operational cash generation and disciplined capex support Blue Star's ongoing tier-2/3 market penetration and commercial cooling expansion plans.
⚠ அபாய எச்சரிக்கைகள்
Potential pricing pressure due to BEE energy efficiency rating changes
Working capital cyclicality common to seasonal cooling equipment
👀 கவனிக்க வேண்டியவை
Track complete revenue and margin performance across consumer cooling and commercial segments in the detailed quarterly presentation, along with management commentary on BEE rating changes and inventory liquidation.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Blue Star arm to sell MedTech division for up to ₹40 Cr via slump sale
Blue Star Limited's wholly owned subsidiary, Blue Star Engineering & Electronics Limited, has executed a Business Transfer Agreement to sell its MedTech division to Cyrix Healthcare for up to ₹40 crore. The division contributed ₹42.13 crore in revenue (0.33% of consolidated revenue) and ₹7.11 crore in net worth (0.21% of consolidated net worth) during FY26. The transaction is being undertaken to sharpen focus on core strategic priorities and is expected to complete by March 31, 2027.
உச்சம் நம்பிக்கை
என்ன மாறியதுBlue Star's subsidiary executed an agreement to divest its medical diagnostic equipment and services (MedTech) business to Cyrix Healthcare.
ஏன் இது முக்கியம்The disposal sheds a non-core, sub-1% revenue unit at an exit valuation above book value, allowing the group to concentrate resources on HVAC, commercial refrigeration, and exports.
📅 குறுகிய காலம்Minimal financial and market impact in the short term given the division's negligible contribution to Blue Star's ₹12,520 Cr TTM top-line.
📈 நீண்ட காலம்Supports strategic focus by exiting a non-core segment and reallocating management bandwidth toward core consumer and commercial cooling opportunities.
⚠ அபாய எச்சரிக்கைகள்
Fulfillment of conditions precedent prior to March 31, 2027 closing
👀 கவனிக்க வேண்டியவை
Track fulfillment of conditions precedent ahead of the March 31, 2027 completion deadline and monitor redeployment of capital into core cooling segments.
Blue Star Q1 FY27: Segment II Margins Drop to 2.9% Amid Pricing Pressure; Order Book at Rs 7,764 Cr
Blue Star reported a challenging Q1 FY27 where Segment II (Room AC) EBIT margins contracted sharply to 2.9% from 5.8% YoY, primarily due to an inability to pass on 13% in input cost hikes. While overall revenue grew 13%, the company faced headwinds from a late summer and high trade inventory, resulting in only 5% of costs being passed to consumers. Conversely, the B2B segment remains robust with a record carried-forward order book of Rs 7,764 Cr, including Rs 1,500 Cr in new data center MEP orders. Management expects a recovery in the second half, targeting a full-year Segment II operating margin of 6.5%.
உச்சம் நம்பிக்கை
என்ன மாறியதுSignificant margin contraction in the Room AC segment due to competitive pricing and unabsorbed commodity costs, despite steady revenue growth.
ஏன் இது முக்கியம்The results highlight intense competition in the consumer AC market, making the company increasingly dependent on its high-growth B2B data center cooling segment to sustain overall profitability.
Segment II EBIT Margin: 2.9%Carried Forward Order Book: Rs 7,764 கோடிOrder Book vs TTM Revenue: 64.04%Data Center Order Inflow (Q1): Rs 1,500 கோடிNet Cash Position: Rs 900 கோடிUnrecovered Cost Hike: 8%
📅 குறுகிய காலம்The stock may face pressure due to the margin disappointment in the core consumer segment, with recovery contingent on festive season demand.
📈 நீண்ட காலம்Structural growth in data center cooling and a strong B2B order book provide a long-term hedge against the volatile and competitive consumer AC market.
⚠ அபாய எச்சரிக்கைகள்
Intense pricing competition in RAC segment
Commodity price and exchange rate volatility
BEE rating change-led inventory liquidation risks
👀 கவனிக்க வேண்டியவை
Monitor the company's ability to 'rejig' its product portfolio and implement price hikes during the Q3 festive season. Watch for potential pricing pressure in December 2026 due to the BEE energy rating change and inventory liquidation.
Blue Star Q1 FY27: Revenue up 13% to ₹3,378 Cr, but PBT drops 24% on margin pressure
Blue Star reported a 13.3% YoY revenue growth to ₹3,378 Cr for Q1 FY27, supported by strong demand in data centers and Room ACs. However, profitability was significantly impacted, with Profit Before Tax (PBT) falling 24% to ₹126 Cr compared to ₹165 Cr in Q1 FY26. EBITDA margins contracted from 6.7% to 5.2% due to rising input costs and the depreciation of the Indian Rupee. While the Electro-Mechanical segment saw strong order bookings, the MedTech business continues to face regulatory headwinds.
உச்சம் நம்பிக்கை
என்ன மாறியதுBlue Star has reported a significant divergence between top-line growth and bottom-line performance, with margins hitting a multi-quarter low despite robust sales.
ஏன் இது முக்கியம்The margin compression in the core Room AC business, despite revenue growth, suggests intense competition or cost-push inflation that the company is struggling to pass on, which is critical for a stock trading at a high P/E of 59.5.
📅 குறுகிய காலம்The stock may face downward pressure in the short term as the market reacts to the 24% decline in PBT and the sharp contraction in operating margins.
📈 நீண்ட காலம்Long-term growth depends on the successful scaling of the US/Europe export business and capturing the data center cooling market, though margin stability remains a key structural concern.
⚠ அபாய எச்சரிக்கைகள்
Input cost inflation
Currency depreciation (INR)
Regulatory uncertainty in MedTech
Pricing pressure from BEE rating changes
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's ability to pass on rising input costs in the Unitary Products segment and watch for the impact of the BEE energy efficiency rating change scheduled for December 2025 on inventory liquidation.
13.3% Revenue Growth in Q1FY27; Net Profit Drops 15% Amid Sharp Margin Contraction
Blue Star reported a 13.3% YoY revenue growth to ₹3,377.92 cr for Q1FY27, but net profit declined by 15.1% to ₹102.53 cr. The Unitary Products (RAC) segment saw margins collapse from 5.8% to 2.9% due to inventory liquidation and high commodity costs. A bright spot is the carried-forward order book, which grew 13.5% YoY to ₹7,764.38 cr, driven by strong demand from data centers. The company also significantly improved its net cash position to ₹900.25 cr through efficient working capital management.
உச்சம் நம்பிக்கை
என்ன மாறியதுBlue Star experienced a significant margin squeeze in its consumer cooling business despite healthy top-line growth, primarily due to commodity price hikes and a shorter-than-expected summer season.
ஏன் இது முக்கியம்The results highlight the high sensitivity of the Room AC business to seasonal weather and input costs, though the growing data center cooling segment provides a structural hedge for the long term.
Revenue (Q1FY27): ₹3,377.92 கோடிNet Profit (Q1FY27): ₹102.53 கோடிOrder Book vs TTM Revenue: 64.04%EBITDA லாப வரம்பு: 5.2%Net Cash Position: ₹900.25 கோடிEMP Segment Order Inflow: ₹2,434.78 கோடி
📅 குறுகிய காலம்The stock may face pressure in the short term as the market reacts to the 150 bps drop in EBITDA margins and the 15% decline in bottom-line profit.
📈 நீண்ட காலம்Structural growth remains intact with a target of $100 million in export revenue from FY28 and leadership in the expanding data center cooling market.
⚠ அபாய எச்சரிக்கைகள்
Commodity price volatility
Rupee depreciation
Inventory liquidation pressure before BEE rating change
Geopolitical uncertainty in West Asia affecting international business
👀 கவனிக்க வேண்டியவை
Investors should monitor the recovery of Unitary Product margins in upcoming quarters as the company attempts to pass on cost escalations. Key triggers include the execution of the ₹5,483.73 cr EMP order book and the impact of the BEE energy rating change scheduled for December 2026.
Blue Star Q1 FY27 Results: Rs 9.17 Cr Exceptional Gain and New Independent Director Appointed
Blue Star Limited approved its Q1 FY27 financial results, featuring a standalone exceptional gain of Rs 9.17 Cr from a property sale. The company reported that five of its subsidiaries contributed Rs 235.17 Cr in revenue and Rs 10.08 Cr in PAT for the quarter. Additionally, the board appointed Mr. Nikhilesh Panchal, a senior partner at Khaitan & Co with 35 years of legal experience, as an Independent Director for a five-year term starting August 14, 2026. While the full consolidated P&L was not detailed in the summary, the subsidiary performance indicates steady international operations.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has reported its first-quarter results for FY27 and strengthened its board by appointing a legal and M&A expert as an Independent Director.
ஏன் இது முக்கியம்The exceptional gain provides a minor one-time boost to the bottom line, while the new board appointment brings significant expertise in corporate law and foreign collaborations, supporting Blue Star's aggressive expansion into US and European markets.
Exceptional Income (Property Sale): Rs 9.17 கோடிSubsidiary Revenue (Q1): Rs 235.17 கோடிSubsidiary PAT (Q1): Rs 10.08 கோடிJV Net Loss (Q1): Rs 0.20 கோடிDirector Term: 5 years
📅 குறுகிய காலம்The stock may see neutral to slightly positive movement based on the exceptional gain, though the focus will remain on core operating margins in the air-conditioning segment.
📈 நீண்ட காலம்The appointment of a legal expert to the board is a structural positive for the company's international expansion and technology transfer goals.
⚠ அபாய எச்சரிக்கைகள்
Pricing pressure due to BEE rating changes
Inventory liquidation risks
MedTech segment de-growth
👀 கவனிக்க வேண்டியவை
Investors should review the full Q1 FY27 financial statement to assess if the 8.4% margins in the UP segment are being maintained despite the BEE energy efficiency rating changes and inventory liquidation pressures mentioned in previous filings.
Blue Star Wins Arbitration; Rs 461.74 Cr Claim by W.J. Towell & Co Dismissed
Blue Star Limited has received a favorable award from the International Chamber of Commerce (ICC) dismissing all claims filed by W.J. Towell & Co LLC (WJT). The revised claim amount was OMR 21,180,748 (approx. Rs 461.74 crore) plus 7% interest, which represented nearly 100% of Blue Star's TTM Net Profit of Rs 462 crore. The arbitrator has dismissed the entire claim, though the final award regarding interest and legal costs is still reserved for a future date. This outcome removes a significant contingent liability that had been pending since early 2024.
உச்சம் நம்பிக்கை
என்ன மாறியதுA major international arbitration proceeding against Blue Star has concluded with a total dismissal of all claims made by the counterparty.
ஏன் இது முக்கியம்The claim amount was highly material, roughly equal to the company's entire annual profit (TTM PAT Rs 462 cr). Its dismissal prevents a potential massive one-time hit to the bottom line and protects the company's net worth.
Dismissed Claim Amount: Rs 461.74 கோடிClaim vs TTM PAT: 99.94%Claim vs Net Worth: 15.09%Interest Rate Claimed: 7%
📅 குறுகிய காலம்The stock is likely to react positively as the market prices out the risk of a significant legal payout.
📈 நீண்ட காலம்The resolution protects the company's capital for its stated 20-25% growth strategy and expansion into US/Europe markets.
⚠ அபாய எச்சரிக்கைகள்
Potential for counterparty to challenge the award in local courts
👀 கவனிக்க வேண்டியவை
Investors should note the removal of this significant legal overhang; the next step is to wait for the final award regarding the recovery of legal costs and interest.
Blue Star Proposes ₹8.5 Final Dividend; 78th AGM Scheduled for August 6, 2026
Blue Star Limited has issued a notice for its 78th Annual General Meeting (AGM) to be held on August 6, 2026. The primary agenda includes the declaration of a final dividend of ₹8.5 per equity share (face value ₹2) for FY26. The company has fixed July 17, 2026, as the record date for dividend eligibility. With a TTM revenue of ₹12,124 Cr and a PAT of ₹462 Cr, the proposed dividend represents a payout based on a stable financial performance in the previous fiscal year.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has formalized the date for its 78th AGM and confirmed the specific dividend amount and record date for shareholders.
ஏன் இது முக்கியம்This is a routine but significant event for shareholders to receive their annual return on investment and vote on key items like director re-appointments and auditor remuneration.
Final Dividend: ₹8.5 per shareரெக்கார்ட் தேதி: ஜூலை 17, 2026Dividend Yield (approx): 0.50%TTM வருவாய்: ₹12,124 கோடிTTM PAT: ₹462 கோடி
📅 குறுகிய காலம்The stock may see minor price adjustments around the ex-dividend date (typically one day before the record date) as the market factors in the ₹8.5 payout.
📈 நீண்ட காலம்Limited; this is a routine administrative filing. Long-term focus remains on the company's expansion into US/Europe markets and market share gains in the Room AC segment.
👀 கவனிக்க வேண்டியவை
Investors should note the record date of July 17, 2026, to be eligible for the ₹8.5 dividend. The upcoming Q1 FY27 results in August 2026 will be the next major catalyst to monitor for growth execution.
₹8.5 Dividend Proposed; Blue Star Schedules 78th AGM for August 6, 2026
Blue Star Limited has issued the notice for its 78th Annual General Meeting (AGM) scheduled for August 6, 2026. The primary agenda includes the declaration of a final dividend of ₹8.5 per equity share (425% of face value) for FY26. The company has fixed July 17, 2026, as the record date for determining dividend eligibility. This follows a financial year where the company reported TTM revenue of ₹12,124 Cr and a PAT of ₹462 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has formalized the date for its 78th AGM and confirmed the specific dividend amount and record date for FY26.
ஏன் இது முக்கியம்This is a routine but significant event for shareholders as it confirms the timing of cash returns (dividend) and provides the full Integrated Annual Report for detailed operational review.
Final Dividend: ₹8.5 per shareDividend Yield (at current price): 0.50%ரெக்கார்ட் தேதி: ஜூலை 17, 2026TTM வருவாய்: ₹12,124 கோடிTTM PAT: ₹462 கோடி
📅 குறுகிய காலம்The stock may see minor price adjustments around the July 17 record date as it goes ex-dividend.
📈 நீண்ட காலம்Limited structural significance from this filing; long-term focus remains on the company's 20-25% growth target and market share expansion in the Room AC segment.
👀 கவனிக்க வேண்டியவை
Investors should note the record date of July 17, 2026, to be eligible for the ₹8.5 dividend. Review the Integrated Annual Report for updates on the US/Europe export strategy and MedTech segment recovery.
Blue Star Announces ₹8.5 Dividend for FY26; Record Date Set for July 17, 2026
Blue Star Limited has recommended a final dividend of ₹8.5 per equity share (face value ₹2) for the financial year ended March 31, 2026. The company has established July 17, 2026, as the record date to determine eligibility for the payout, which is subject to shareholder approval at the AGM on August 6, 2026. Tax Deduction at Source (TDS) will apply at 10% for resident individuals with a valid PAN if the dividend exceeds ₹10,000, and 20% for those without. Non-resident shareholders may claim treaty benefits by submitting required documentation by July 10, 2026.
முக்கிய அம்சங்கள்
Recommended final dividend of ₹8.5 per equity share of face value ₹2 for FY 2025-26.Record date for determining dividend entitlement is fixed as Friday, July 17, 2026.Dividend payment is scheduled to occur after the Annual General Meeting on August 6, 2026.Standard TDS rate of 10% for resident individuals with PAN; 20% for non-residents or those without PAN.Deadline for submitting tax-related exemption documents is Friday, July 10, 2026.
👀 கவனிக்க வேண்டியவை
Investors should ensure their PAN and bank account details are updated with their Depository Participant and submit tax exemption forms by July 10 to avoid higher TDS. To be eligible for the ₹8.5 dividend, shares must be held in the portfolio as of the record date, July 17, 2026.
Blue Star to Acquire Remaining 51% Stake in Blue Star Qatar for up to ₹50 Lakh
Blue Star Limited has approved the acquisition of the remaining 51% shareholding in its subsidiary, Blue Star Qatar W.L.L. (BSQ), from its local partner Al Malki Trading & Contracting Co. Although Blue Star already held 95% economic interest and management control, this move will make BSQ a wholly-owned subsidiary. The acquisition follows regulatory changes in Qatar that now permit 100% foreign ownership. The total consideration is capped at ₹50 lakh, and the transaction is expected to be completed within eight months.
முக்கிய அம்சங்கள்
Acquisition of 51% stake in Blue Star Qatar W.L.L. to convert it into a wholly-owned subsidiaryTotal cash consideration for the 51% stake is capped at ₹50 lakhBlue Star Qatar reported a turnover of QAR 25 million for FY26, down from QAR 53 million in FY24The move simplifies the corporate structure following Qatar's regulatory shift to allow 100% foreign ownershipTransaction is subject to approvals from the RBI and Qatari authorities, with an 8-month completion target
👀 கவனிக்க வேண்டியவை
This is a minor structural simplification with negligible financial impact on Blue Star's consolidated performance. Investors should remain focused on the company's primary growth drivers in the Indian cooling and MEP markets.
Blue Star Q4 FY26 Revenue Hits Record ₹4,072 Cr; Recommends ₹8.5 Dividend
Blue Star reported its highest-ever quarterly revenue of ₹4,072 crore in Q4 FY26, marking a 1.3% YoY growth despite a challenging year. While annual net profit for FY26 declined by 4.3% to ₹527.3 crore due to supply chain headwinds and a weak initial summer, the company's order book remains robust at ₹6,923 crore. The Board has recommended a dividend of ₹8.5 per share. Management expressed cautious optimism for FY27, citing a strong start to the summer season in April 2026.
முக்கிய அம்சங்கள்
Q4 FY26 consolidated revenue grew 1.3% YoY to ₹4,072 crore, while EBITDA margins improved to 8%.Full-year FY26 revenue increased 3.6% to ₹12,402 crore, though net profit fell to ₹527.3 crore.The carried forward order book grew by 10.5% YoY to reach ₹6,923 crore as of March 31, 2026.Unitary Products (Segment 2) margins improved to 10.4% in Q4 FY26 from 8.4% in the previous year.Board recommended a dividend of ₹8.5 per share for the financial year ended March 31, 2026.
👀 கவனிக்க வேண்டியவை
Investors should focus on the recovery in the room air conditioner segment and the strong order book in electromechanical projects. While Q4 showed margin improvement, watch for the impact of rising input costs and geopolitical supply chain disruptions in FY27.
Blue Star Q4 Net Profit Rises 17% to ₹227 Cr; FY26 Dividend Recommended at ₹8.5 Per Share
Blue Star reported a modest 1.3% revenue growth in Q4FY26 to ₹4072.06 cr, though net profit surged 17.1% to ₹227.18 cr driven by improved EBITDA margins of 8.0%. For the full year FY26, the company faced headwinds with net profit declining 10.8% to ₹527.33 cr, primarily due to a challenging environment and exceptional items related to labor codes. The order book remains healthy at ₹6923 cr, up 10.5% YoY, providing revenue visibility for the upcoming year. The Board recommended a dividend of ₹8.5 per share, slightly lower than the previous year's ₹9.
முக்கிய அம்சங்கள்
Q4FY26 Net Profit grew 17.1% YoY to ₹227.18 cr, while Revenue saw a marginal 1.3% increase to ₹4072.06 cr.Full-year FY26 Net Profit declined by 10.8% to ₹527.33 cr despite a 3.6% growth in total revenue to ₹12401.99 cr.Carried-forward order book grew 10.5% to ₹6923 cr as of March 31, 2026, with strong Q4 order inflows in the Projects segment.Unitary Products (AC segment) margins improved significantly to 10.4% in Q4 from 8.4% YoY due to cost rationalization.Recommended dividend of ₹8.5 per share for FY26, representing a slight decrease from ₹9.0 in FY25.
👀 கவனிக்க வேண்டியவை
Investors should monitor the sustainability of the margin expansion in the Unitary Products segment and the execution of the ₹6,923 cr order book. While full-year profits were down, the strong Q4 performance and pickup in summer demand in April 2026 suggest a potential recovery in FY27.
Blue Star Q4 FY26 EBITDA Grows 16.8% to ₹326 Cr; Revenue Hits ₹4,072 Cr
Blue Star reported a steady Q4 FY26 with revenue growing marginally to ₹4,072 crore, while EBITDA saw a significant 16.8% increase to ₹326 crore. The Unitary Products segment (Room ACs) showed margin improvement to 10.4% despite stagnant growth in deep freezers. However, full-year EPS declined to ₹25.65 from ₹28.76, impacted by a ₹38 crore exceptional one-time charge related to new labor codes. The company maintains a healthy balance sheet with a net cash position of ₹175 crore and a low debt-equity ratio of 0.18.
முக்கிய அம்சங்கள்
Q4 FY26 EBITDA increased to ₹326 crore from ₹279 crore in the previous year, with margins improving to 8.0%.Unitary Products EBIT margins improved significantly to 10.4% in Q4 FY26 from 8.4% YoY.Electro-Mechanical Projects (EMP) order bookings grew by 35% driven by demand from Data Centers and Factories.Full-year FY26 revenue reached ₹12,402 crore, though EPS fell to ₹25.65 due to a ₹38 crore exceptional gratuity impact.Net cash position decreased to ₹175 crore from ₹640 crore YoY, while the debt-equity ratio remains low at 0.18.
👀 கவனிக்க வேண்டியவை
Investors should monitor the margin recovery in the EMP segment and the scalability of the US/Europe expansion. While Q4 was strong, the full-year earnings dip and lower net cash suggest a need for a cautious outlook on immediate valuation upside.
Blue Star Q4 FY26 Revenue Grows 12% to ₹2,790 Cr; EBITDA Margins Expand to 8%
Blue Star reported a steady Q4 FY26 with revenue growing 12% YoY to ₹2,790 crore and EBITDA margins improving to 8% from 7% in the previous year. While the full-year revenue grew modestly by 3.6% to ₹12,402 crore, the company faced a one-time exceptional hit of ₹38 crore due to new labor code provisions affecting full-year EPS. Segment 1 (EMP) saw strong order booking growth of 35% in Q4, while Segment 2 (Unitary Products) margins improved significantly to 10.4%. The company maintains a healthy balance sheet with a low debt-equity ratio of 0.18.
முக்கிய அம்சங்கள்
Q4 FY26 Revenue increased 12% YoY to ₹2,790 crore, with EBITDA rising 16.8% to ₹326 crore.Unitary Products (Room ACs) segment EBIT margins improved to 10.4% in Q4 from 8.4% YoY.Electro-Mechanical Projects (EMP) saw a robust 35% growth in order bookings during the quarter.Full-year FY26 results were impacted by a ₹38 crore exceptional charge for gratuity and leave encashment.Net cash position decreased to ₹175 crore from ₹640 crore, while Debt-Equity ratio remains low at 0.18.
👀 கவனிக்க வேண்டியவை
Investors should focus on the strong margin recovery in the Unitary Products segment and the robust order pipeline in EMP. The stock remains a solid play on India's cooling and infrastructure growth, though full-year growth was slightly muted due to one-off costs.
Blue Star Recommends ₹8.5 Dividend; Approves Audited FY26 Financial Results
Blue Star's Board has recommended a final dividend of ₹8.5 per equity share (425% of face value) for the financial year ended March 31, 2026. The company approved its audited financial results for FY26, which received an unmodified opinion from statutory auditors Deloitte Haskins & Sells LLP. The record date for the dividend is set for July 17, 2026, with the payout expected after the Annual General Meeting on August 6, 2026. This announcement signals a steady return to shareholders alongside the completion of the fiscal year.
முக்கிய அம்சங்கள்
Recommended a final dividend of ₹8.5 per equity share of ₹2 face value for FY26.Fixed July 17, 2026, as the Record Date for determining dividend eligibility.Approved audited standalone and consolidated financial results for the year ended March 31, 2026.Statutory auditors issued an unmodified audit report, confirming financial transparency.The 78th Annual General Meeting (AGM) is scheduled for August 6, 2026.
👀 கவனிக்க வேண்டியவை
Investors seeking dividend income should ensure they hold shares by the record date of July 17, 2026. The clean audit report and substantial dividend payout suggest stable financial health for the company.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
